![Eric Lohrer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eric Lohrer active positions
Companies | Position | Start | End |
---|---|---|---|
Helvetica Capital AG
![]() Helvetica Capital AG Investment ManagersFinance Helvetica Capital AG is an independent private equity/venture capital firm headquartered in Zurich, Switzerland. The firm was founded in August 2015 by Johannes Suter. | Private Equity Investor | - | - |
Amazentis SA
![]() Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | Director/Board Member | 2015-10-31 | - |
Career history of Eric Lohrer
Statistics
International
Switzerland | 3 |
Operational
Private Equity Investor | 1 |
Director/Board Member | 1 |
Sectoral
Finance | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Helvetica Capital AG
![]() Helvetica Capital AG Investment ManagersFinance Helvetica Capital AG is an independent private equity/venture capital firm headquartered in Zurich, Switzerland. The firm was founded in August 2015 by Johannes Suter. | Finance |
Amazentis SA
![]() Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | Commercial Services |
- Stock Market
- Insiders
- Eric Lohrer
- Experience